Cancer

Actuate to Present Promising Data on Elraglusib in Advanced Salivary Gland Carcinoma at the AACR Annual Meeting 2025

CHICAGO and FORT WORTH, Texas, April 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”),…

8 months ago

Profound Medical to Release First Quarter 2025 Financial Results on May 8 – Conference Call to Follow

TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device…

8 months ago

Calidi Biotherapeutics Announces FDA Clearance of IND Application for CLD-201 in Solid Tumors

SAN DIEGO, April 17, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company pioneering…

8 months ago

Victoza Weight Loss: Buy OTC Victoza For Weight Loss Medication Alternative From PhenQ – Real Reviews

phenq Phenq Albany, New York, April 17, 2025 (GLOBE NEWSWIRE) -- In thе last 30 yеars and thе Amеricas havе…

8 months ago

Do Probiotics Make You Poop? Probiotic & Prebiotic Supplement For Constipation From YourBiology

Do Probiotics Make You Poop? Yes and No – Read Probiotics for Constipation: Everything You Need to Know YourBiology YourBiology…

8 months ago

Bright Peak Therapeutics Appoints John Schmid to its Board of Directors

SAN DIEGO and BASEL, Switzerland , April 17, 2025 (GLOBE NEWSWIRE) -- Bright Peak Therapeutics, a clinical-stage biotechnology company focused…

8 months ago

Greater Precision of HER2-Expressing Breast Cancer Treatment with 3D Pathology: New JelloX Research Collaboration

In the preliminary findings of a study conducted with the National Taiwan University Hospital, over 50% of sample cases were…

8 months ago

Saudi Arabia and France Strengthen Health Cooperation Through Strategic Agreements in Biotech and Digital Health

PARIS, April 16, 2025 /PRNewswire/ -- On the second day of an official visit to France, His Excellency Fahad Abdulrahman…

8 months ago

Clearmind Medicine Launches First U.S. Clinical Site for its FDA-Approved Clinical Trial to Combat Alcoholism

Vancouver, Canada, April 16, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a…

8 months ago